Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (JNJ)
NYSE:JNJ
JNJ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$140.68 - $168.85
Previous CloseN/A
Volume3.80M
Average Volume (3M)9.15M
Market Cap
$375.95B
Enterprise Value$365.36B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)27.0
Beta0.29
Next Earnings
Apr 15, 2025EPS Estimate
2.65Last Dividend Ex-Date
Feb 18, 2025Dividend Yield3.17%
Share Statistics
EPS (TTM)5.80
Shares Outstanding2,407,616,700
10 Day Avg. Volume8,095,461
30 Day Avg. Volume9,147,361
Standard Deviation0.05
R-Squared0.29
Alpha-0.00226
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.23
Price to Cash Flow (P/CF)13.50
P/FCF Ratio13.50
Enterprise Value/Market Cap0.97
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.78
Enterprise Value/Ebitda12.81
Forecast
1Y Price Target
$167.50Price Target Upside8.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceResults in 4Q beat expectations on the top and bottom line.
Growth StrategyThe planned acquisition of ITCI should add an important growth driver in Caplyta.
Product DevelopmentThe Innovative Medicine Unit helped drive better-than-anticipated 4Q results.
Bears Say
Competitive ChallengesUS knees and hips performance was soft, with competitive pressures accelerating in the electrophysiology sector.
Financial GuidanceNew 2025 FY guidance shows revenues below consensus, mostly due to foreign exchange impacts.
Regulatory And Policy ChallengesHeadwinds from China VBP and anti-corruption policy may be worse than previously anticipated, affecting sales growth.
---
Ownership Overview
0.04% Insiders
18.44% Mutual Funds
14.13% Other Institutional Investors
47.39% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $140.68 and its highest was $168.85 in the past 12 months.
What is Johnson & Johnson’s market cap?
Johnson & Johnson’s market cap is $375.95B.
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Apr 15, 2025 which is in 55 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Jan 22, 2025. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.992 by $0.048.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of $1.24 which represents an annual dividend yield of 3.17%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is 2.65.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,407,616,700 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of $2.04 in its last earnings report, beating expectations of $1.992. Following the earnings report the stock price went down -1.939%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Currently, no hedge funds are holding shares in JNJ
---
Johnson & Johnson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$167.50 (8.07% Upside)
$167.50 (8.07% Upside)
Blogger Sentiment
Bullish
JNJ Sentiment 92%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 409.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
―
20 days / 200 days
Momentum
3.43%
12-Months-Change
Fundamentals
Return on Equity
111634.92%
Trailing 12-Months
Asset Growth
7.49%
Trailing 12-Months
Company Description
Johnson & Johnson
Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
---
JNJ Company Deck
---
JNJ Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Johnson & Johnson showed robust growth in sales and innovation in 2024, particularly in the Innovative Medicine and MedTech sectors. However, earnings were negatively impacted by STELARA biosimilars and recent acquisitions, while challenges in China and decreased margins were noted.Read More>---
JNJ Sales Breakdown
64.13% Innovative Medicine
35.87% MedTech
---
JNJ Stock 12 Month Forecast
Average Price Target
$167.50
▲(8.07% Upside)
Technical Analysis
Best Analysts Covering JNJ
1 Year
1 Year Success Rate
23/23 ratings generated profit
1 Year Average Return
+9.41%
reiterated a buy rating 9 months ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.41% per trade.
---